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Abstract
Background: Progressive retinal atrophy (PRA) belongs to a group of inherited retinal disorders associated with
gradual vision impairment due to degeneration of retinal photoreceptors in various dog breeds. PRA is highly
heterogeneous, with autosomal dominant, recessive or X-linked modes of inheritance. In this study we used exome
sequencing to investigate the molecular genetic basis of a new type of PRA, which occurred spontaneously in a
litter of German short-hair Weimaraner dogs.
Results: Whole exome sequencing in two PRA-affected Weimaraner dogs identified a large deletion comprising the
first four exons of the X-linked retinitis pigmentosa GTPase regulator (RPGR) gene known to be involved in human
retinitis pigmentosa and canine PRA. Screening of 16 individuals in the corresponding pedigree of short-hair
Weimaraners by qPCR, verified the deletion in hemizygous or heterozygous state in one male and six female dogs,
respectively. The mutation was absent in 88 additional unrelated Weimaraners. The deletion was not detectable in
the parents of one older female which transmitted the mutation to her offspring, indicating that the RPGR deletion
represents a de novo mutation concerning only recent generations of the Weimaraner breed in Germany.
Conclusion: Our results demonstrate the value of an existing DNA biobank combined with exome sequencing to
identify the underlying genetic cause of a spontaneously occurring inherited disease. Identification of the genetic
cause has allowed the development of a diagnostic test, which should help to eradicate the PRA causing mutation
from the respective canine line. Thus, planning of future pairings is facilitated and manifestation of this type of PRA
can be prevented.
Keywords: Progressive retinal atrophy, Exome sequencing, RPGR (retinitis pigmentosa GTPase regulator) gene,
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Plain English Summary
Progressive retinal atrophy (PRA) affects cats and dogs,
initially causing night blindness, followed by gradual visual
loss and finally blindness. PRA comprises a large group of
genetically heterogeneous retinal diseases with similar
clinical appearance but differing in age of onset and rate
of disease progression. Mutations in more than 20 genes
are known to cause canine PRA, but the genetic cause of
PRA in several affected breeds still remains to be identi-
fied. Most forms of canine PRA are inherited in an auto-
somal recessive manner, caused by mutations in the same
gene transmitted from both parents. Autosomal dominant
inheritance, in which one mutation suffices to cause the
disease, is rarely observed. Three X-linked forms have
been found to be caused by different mutations in the ca-
nine retinitis pigmentosa GTPase regulator (RPGR) gene.
Since a new type of PRA was diagnosed in a single litter
of Weimaraner dogs in March 2015, we investigated all
genes of two affected males in comparison with healthy
controls. We analysed the DNA of all coding parts of the
genes (known as exons) using exome sequencing analysis.
A large gap was identified in the RPGR gene, i.e. a deletion
comprising the first four exons. The X-linked RPGR gene
is known to be involved in both human retinitis pigment-
osa and canine PRA. Screening of affected and healthy
Weimaraners revealed the new mutation in hemizygous
state in one affected male and in heterozygous state in six
mildly affected or asymptomatic female dogs, whereas it
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was absent in all unrelated Weimaraners investigated. The
deletion was not present in the parents of one older fe-
male which transmitted the mutation to her offspring.
This indicates that the RPGR gene was newly mutated in
this female or in the parental sperm or egg, respectively.
The established DNA test allows easy mutation detection
and helps the breeder community to plan future pairings
for the next generations of Weimaraners without this type
of PRA.
Background
Retinal dystrophies are a common cause of blindness in
both human beings and purebred dogs (Canis familiaris).
The most typical form of canine dystrophy is PRA which
is an equivalent in phenotype and disease progression to
retinitis pigmentosa (RP) in man [1]. PRA encompasses a
large group of genetically heterogeneous retinal dystro-
phies that share a similar phenotype of progressive visual
impairment, finally leading to blindness. Initially, rod
photoreceptor vision is affected resulting in night blind-
ness, followed by progressive loss of cone photoreceptors
with deterioration in daytime vision [2]. In other forms of
retinal diseases such as cone-rod dystrophy and achroma-
topsia, daytime vision is impaired prior to night vision [3].
PRA has been documented in more than 100 different
dog breeds [2]. To date, mutations in at least 20 genes
have been associated with PRA [4]. However, the genetic
cause of PRA in several affected breeds still remains to be
identified. Most forms of canine PRA are inherited in an
autosomal recessive manner, but an autosomal dominant
trait [5] as well as three X-linked forms are also known
[6–8] which arose independently as single mutation
events [9]. The different forms of PRA can be classified by
the age of onset of night blindness and the rate of disease
progression (i.e., vision loss) [2].
In Germany, in March 2015, several litter mates of
Weimaraners (Fédération Cynologique Internationale
group 7, section 1, standard No. 99) aged ~2.5 years
were ophthalmologically diagnosed with a bilateral
retinal dystrophy resembling PRA. The Weimaraner, ori-
ginally designated as Weimar pointer, represents a native
old German breed of hunting dogs. Its origin can be
traced back to the 18th century when the first breed
standard was established [10]. With about 500 puppies
per year in Germany (http://www.vdh.de/ueber-den-vdh/
welpenstatistik/; Verband für das Deutsche Hundewesen,
VDH) the Weimaraner does not have a particularly
small population base. Hence, the molecular genetic
basis of PRA in this breed was studied using next gener-
ation sequencing (NGS). A large deletion was identified
in the RPGR gene, mutations of which have been re-
ported to cause X-linked RP (XLRP) in man [11] and X-
linked PRA in dogs [7].
Methods
Dogs
All investigated dogs originated from the common breed-
ing population of pure-bred short-hair Weimaraners.
Veterinarians who were specialized and experienced in
ophthalmological diseases (Dortmunder Kreis, DOK)
confirmed the PRA status of affected male dogs (n = 3;
Fig. 1b) and of female dogs with mild symptoms (n = 3) by
ophthalmoscopy, as documented in certificates of eye
examinations. For all other dogs, general veterinarian ex-
aminations revealed normal sight as prerequisite for
breeding. In total, blood samples of 108 dogs were received
from the owners either submitted to the Weimaraner DNA
biobank (established at the Department of Human Genet-
ics, Ruhr-University Bochum, Germany) or sent to our in-
stitute for other research projects such as investigation of
genetic variability in the Weimaraner population. Written
informed consent was obtained from the owners for sam-
ple collection and genetic investigations. Sample collec-
tion was performed by practicing veterinarians according
to international guidelines for the use of laboratory ani-
mals. As the DNA stems from the blood of client-owned
dogs that underwent routine veterinary examinations in-
cluding venipuncture, animal experiments were not
A B
Fig. 1 Ophthalmoscopic appearance of the central fundus. a Healthy unrelated female Weimaraner dog (~3 years) with a normally appearing
fundus (right eye). b PRA-affected male Weimaraner dog (~2.5 years) showing the typical landmarks of PRA with vessel attenuation primarily of
the arterioles in the papillary area and a hyperreflective tapetum lucidum (left eye)
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performed and, therefore,approval by an ethical commit-
tee was not necessary. Genomic DNA was isolated from
peripheral blood cells using a standard protocol [12]. To
test matrilineal inheritance of PRA in Weimaraners, mito-
chondrial genome sequencing was performed in one
PRA-affected dog and his mother.
For whole exome sequencing, we used the genomic
DNA of four male Weimaraners, two of them diagnosed
with PRA and two healthy control dogs older than the
early age of onset (~2.5 years) of this PRA form in
Weimaraner dogs. To verify co-segregation, identified
variants were investigated in both PRA-affected dogs
and their parents by Sanger sequencing. For extended
segregation analysis, a pedigree was available comprising
18 Weimaraners, including the two male dogs diagnosed
with PRA, their parents, maternal grandparents and two
siblings as well as three further breeding partners of the
mother and seven half-siblings (Fig. 2a). A cohort of 88
healthy control Weimaraners (41 male, 47 female) which
were unrelated to the PRA-affected line for at least five
generations was used for validation purposes in case of
co-segregation of putative disease causing variants and
structural abnormalities using restriction fragment
length polymorphism (RFLP) and quantitative real-time
PCR (qPCR) analyses, respectively. 90 % of these 88 con-
trol dogs were born at least 10 years ago, the youngest
male control dogs are 8 and 9 years old by now, respect-
ively. With an average life expectancy of about 12 years,
most of the controls are already deceased today. None of
the male (and female) control dogs had been reported to
the DNA biobank registry as showing restrictions in the
visual system to date. All potentially inherited medical
impairments are registered in the DNA biobank files of
the respective dogs.
NGS-based mutation screening
Whole exome sequencing was performed on four
Weimaraner DNAs (including two of the dogs diagnosed
with PRA). The canine exome library consisted of a cus-
tom track ordered from Agilent (Santa Clara, CA, USA)
as a 54 Mb design. Therefore, tracks of the UC Santa
Cruz Genomics Institute (UCSC) Genome Browser from
the dog (Canis familiaris) whole genome shotgun
(WGS) assembly v.2.0 (CanFam2 May 2005) were used
as references for the Ensembl Genome Browser (http://
www.ensembl.org/index.html) as well as tracks of the
National Center for Biotechnology Information (NCBI)
reference sequence database (https://www.ncbi.nlm.nih.-
gov/refseq/rsg/), human protein alignments and spliced
expressed sequence tags (EST) that lie outside the tracks
of the Ensembl Genome Browser. Sequencing was
performed on an Ilumina HiSeq 2000 platform
(Illumina Inc., San Diego, CA) at the Cologne Center
for Genomics (CCG, Köln, Germany) using a single lane
per sample, generating paired-end reads of 2x100 nucleo-
tides (nt) in length and yielding an average coverage of
~60x. Fastq files were further processed using the Next-
GENe® software (Softgenetics, State College, PA, USA) ac-
cording to the manufacturer’s protocol. Sequences were
aligned to the available reference tracks CanFam2 and
xenoRefGene.txt corresponding to the best blast align-
ment of known genes from other species (available from
UCSC Genome Browser, http://hgdownload.cse.ucsc.edu/
goldenPath/canFam2/database/) using standard settings.
99.1 % of the reads matched to the reference genome with
82.9 % matching perfectly.
Mutations were called using the NextGENe® software
standard settings for a retinal candidate gene panel as
well as for the entire exome. For initial retinal candidate
gene analysis, a panel of all known RP-associated and
retina-specific genes was created based on retinal candi-
date genes listed by Kastner et al. [13] and complemen-
ted by candidate genes from the Retinal Information
Network (RetNet, http://www.sph.uth.tmc.edu/retnet/)
database as well as from recent literature. Since the
mode of inheritance of PRA in the Weimaraner breed
was not obvious initially, retinal candidate genes were
included with different modes of inheritance (autosomal
dominant, autosomal recessive and X-linked). Candidate
variants were identified by variant comparison and
copy number variation (CNV) tools integrated in the
NextGENe® software. For variant comparison, PRA-
affected individuals were compared to unaffected indi-
viduals assuming recessive and dominant modes of
inheritance—including the possibility of a heterozy-
gous carrier status in the unaffected dogs in case of
recessive inheritance. For CNV analyses, PRA-affected
individuals were compared to unaffected individuals
using the multiple controls option and the best match
mode.
Variations or structural aberrations were considered
as candidates for further analyses if they were present
at least in heterozygous state in both affected individ-
uals but not in the unaffected ones (dominant model)
or if they were present in homozygous state in the
PRA-affected dogs and absent or in heterozygous state
in the unaffected ones (recessive model). Potential mu-
tations were evaluated in more detail by visualization of
the bam-files (binary version of sequence alignment
map) with the integrative genomics viewer (IGV; [14]).
Diverse online tools and genome browsers, including
UCSC Genome Browser (http://genome.cse.ucsc.edu/),
Ensembl, Online Mendelian Inheritance in Man
(OMIM, http://www.ncbi.nlm.nih.gov/omim), RetNet
and GeneCards (http://www.genecards.org/) were also
used to provide details about conservation, gene ex-
pression, gene function and relevant pathogenic infor-
mation in man.
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Validation of candidate variants and structural
abnormalities
Sanger DNA sequencing of the entire mitochondrial gen-
ome (mtDNA) and potential candidate single nt variants
was carried out using the Big Dye Terminator kit v3.1 on
an ABI 3500XL Genetic Analyzer (Applied Biosystems,
Darmstadt, Germany), as previously described [15]. Se-
quences were evaluated with the Variant Reporter software
(Applied Biosystems) and the SeqManII software (DNAstar,
Madison, WI, USA). For further validation of potential
candidate variants, RFLP analyses were performed as previ-
ously described [15]. For verification of structural
Fig. 2 The deletion in the X chromosomal RPGR gene as identified in a PRA pedigree of Weimaraner dogs via whole exome sequencing; the
breakpoint (BP) region is indicated. a Pedigree structure and RPGR deletion genotypes of 18 investigated individuals of the XLPRA Weimaraner
family. PRA segregates in two generations of the family. Squares represent males, circles indicate females, crossed-out symbols represent deceased
dogs. Filled squares show ophthalmologically diagnosed PRA-affected male dogs. Half-filled circles indicate females with ophthalmologically
confirmed mild PRA symptoms. Open symbols represent male and female dogs with normal sight as revealed by general veterinarian examinations,
respectively. An asterisk below solid square symbols indicates PRA-diagnosed dogs, which were used for whole exome sequencing. Genotypes of RPGR
deletion screening are shown below the symbols. XM (colored in red) refers to an allele with RPGR deletion, X and Y symbols illustrate normal X- (with
wildtype RPGR alleles) and Y-chromosomes, respectively. b Integrated Genomics Viewer (IGV) display of the canine RPGR deletion and surrounding
regions (CFAX: 3310100–33106500, CanFam3.1 UCSC genome browser) as well as graphical illustration of exon-intron boundaries from the 5′UTR to
exon 5. As viewed in IGV, the control and male PRA-affected dog are represented by two separate panels. The upper panel is a histogram where the
height of each mountain-like grey area is representative of the read depth at that location. The lower panel is a graphical view of some of the reads
that align to that location. Lack of reads (horizontal bars in lower panel) is characteristic for complete loss of exonic sequences. The deletion comprising
exons 1–4 (~5 kb) is obvious in the male PRA-affected dog in hemizygous state in contrast to the PRA-unaffected dog. Thus the gap region includes
exon 1 in the canine genomic RPGR sequence explaining only non-specific read alignments in the lower panel for the control. c QPCR-based copy
number analysis of the deleted exons 3–4 and the non-deleted exon 5 of RPGR gene in four individuals of the pedigree of Weimaraners in comparison
to a healthy control. Error bars indicate the standard deviation of three replicates. d Chromatogram and graphical representation of the BP region in
the RPGR gene in a male PRA-affected Weimaraner. The graphical illustration indicates part of intron 4 sequence and of 5′UTR of RPGR. Deleted
sequences of intron 4 and 5′UTR are coloured in light grey, non-deleted sequences are indicated by coloured letters. The BP region comprises three
nucleotides (TTC) from either end which are underlined. The chromatogram also shows the BP (marked with arrows) as well as flanking sequences of
intron 4 and 5′UTR of RPGR as identified in a male PRA-affected Weimaraner
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abnormalities, qPCR was run on the StepOnePlus real
time-PCR system (Applied Biosystems) using the KAPA
SYBR® FASTABI Prism™ One-Step qRT-PCR reagent (peq-
Lab, Erlangen, Germany) as described by the manufac-
turer. Baseline and threshold values were set automatically
and cycle threshold (CT) values were determined using
the StepOnePlus software (Applied Biosystems). Gene
copy numbers were calculated using the ΔΔCT method
[16] with normalization to the X-chromosomal dystrophin
(DMD) gene. Primer sequences used for qPCR are listed
in the Additional file 1.
Primers used for candidate gene and mtDNA sequencing,
RFLP, qPCR analyses and breakpoint PCR were designed
with the LightScanner Primer Design Software v1.0 (Idaho
Technology Inc., Salt Lake City, Utah, USA) according to
the CanFam2 genome sequence with minimization of pos-
sible single nucleotide polymorphisms (SNPs) at the primer
binding sites.
Parentage testing was performed using the microsatellite
marker based parentage testing kit Canine Genotypes Panel
2.1 on the ABI 3500XL Genetic Analyzer (Applied Biosys-
tems) according to the manufacturer’s protocol. For allele
sizing, the GeneScan™ 600 LIZ® Size Standard v2.0 (Thermo
Fisher Scientific, Dreieich, Germany) was used. Raw data of
microsatellite marker testing were automatically analysed
by the ABI 3500XL Genetic Analyzer (Applied Biosystems)
and evaluated using the GeneMapper v4.1 software (Ap-
plied Biosystems). To confirm the results of the parentage
testing kit Canine Genotypes Panel 2.1, DNA profiling was
also performed with parentage testing kit Canine Geno-
types Panel 1.1 (Thermo Fisher Scientific) which is licensed
for parentage testing by the International Society for Ani-
mal Genetics.
RPGR genomic sequence and mutation analyses
The canine genomic RPGR sequences (chrX: 33056371–
33105037, CanFam3.1) were compared to an in silico-
predicted RPGR mRNA in humans (UCSC genome
browser accession NM_000328.2) in order to verify
exon-intron boundaries. Since the genomic database se-
quence includes a gap comprising the 5′UTR, exon 1
with the start codon and parts of intron 1 in the canine
RPGR gene, the respective region was amplified by long-
range PCR (expand high fidelity PCR system; Roche,
Mannheim, Germany) and sequenced with the Sanger
method. The newly identified sequences of the RPGR
gap region were verified by comparisons with the NCBI
database using the Basic Local Alignment Search Tool
(BLAST, http://blast.ncbi.nlm.nih.gov/Blast.cgi).
For deletion size estimation in RPGR, the newly identi-
fied 5′ untranslated region (5′UTR) and part of intron 4
(IVS4) were amplified by PCR using different primer
combinations and sequenced with the Sanger method in
order to identify the recombination breakpoints. One
primer pair was used for breakpoint PCR (diagnostic
test) in order to verify qPCR-based deletion screening
results. Primer sequences used for recombination break-
point analysis are listed in the Additional file 1.
Results
Phenotype of PRA in Weimaraner dogs
Three male German Weimaraner litter mates were sus-
pected to be affected by PRA upon ophthalmoscopic
examination. They showed a significant progressive
night blindness with slightly unsafe behaviour in twilight
because of visual disturbances. Other than in healthy
Weimaraners (Fig. 1a), ophthalmological investigations
revealed PRA-like abnormalities such as diffuse hyperre-
flectivity in the tapetum ludidum, depigmentation in the
non-tapetal part of the fundus and generalised vascular
attenuation (Fig. 1b). All three PRA-affected males
were ~2.5 years of age at the time of diagnosis.
Three female Weimaraner dogs (including the mother
of the PRA-affected litter mates, one sibling and one
half-sibling) showed mild symptoms of PRA at ophthal-
mological investigations such as patchy and diffuse areas
of hypo- and hyperreflectivity in the dorsal tapetum
ludidum, whereas retinal vessels and non-tapetal fundus
were not altered (data not shown). No other symptoms
of PRA were found in the female sibling and the mother
aged ~2.5 years and ~8 years at diagnosis, respectively.
However, the mother was only investigated after the
PRA diagnosis in her offspring. For the female half-
sibling, ~5 years of age at diagnosis, the owners had no-
ticed slightest changes in visual capability. Progression
of retinal degeneration was not documented within the
limited time span since PRA was initially diagnosed in
the Weimaraner (March to December 2015).
Candidate gene and mtDNA screening
Due to the unknown inheritance mode of the PRA form
in the Weimaraner breed and in order to test the hypoth-
esis of non-mendelian inheritance, the mitochondrial gen-
ome (16,727 nt) was analysed for one PRA-affected
Weimaraner and his mother. This analysis revealed identi-
cal mtDNA haplotypes (the matrilineage) in 100 homo-
plasmic and eight heteroplasmic variations in both
individuals and no differences to healthy dogs in the NCBI
database. Thus, no mutation associated with PRA was ob-
vious (data not shown).
Next generation and Sanger sequencing
Whole exome sequencing was performed in two male
PRA-affected and two male healthy control Weimar-
aner dogs. In total, 351,538 sequence variants were
identified. Initial retinal candidate gene panel filtering
for 346 genes (see Additional file 1) causing autosomal
dominant, recessive or X-linked inherited retinal diseases
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revealed no PRA causing mutation for the PRA-affected
dogs. Therefore, comparison analyses of all 351,538 whole
exome sequence variants of PRA-affected versus control
dogs assuming recessive or dominant inheritance were
performed by using the comparison tool of the Next-
GENe® software. In total, 6,805 potentially recessive and
15,135 potentially dominant variants were identified. Most
variants were excluded as causative for PRA due to infor-
mation concerning poorly conserved locations, non-
retina-specific gene expression and function from diverse
public databases. However, four potential variants (two
nonsense and two missense mutations) in the genes endo-
plasmic reticulum aminopeptidase 2 (ERAP2), DnaJ/
Hsp40 homolog, subfamily c, member 4 (DNAJC4), expor-
tin 4 (XPO4) and dihydropyrimidine dehydrogenase
(DPYD) were not excluded by the aforementioned criteria
and subsequently verified by Sanger sequencing. Analyses
of these four sequence variants demonstrated segregation
in both PRA-affected dogs and their parents. However,
RFLP analyses of a cohort of 88 unrelated control Weima-
raners excluded all four variants as causative for PRA
since they were identified in numerous healthy individuals.
Next, comparisons of whole exome CNVs of PRA-affected
versus control Weimaraners were performed by using the
CNV tool of the NextGENe® software. In total, 341 dele-
tions and 552 duplications were identified and verified
with the IGV viewer. Among these, a large deletion of
exon 1–4 of the X-linked RPGR gene was identified in the
PRA-affected Weimaraners, which was not found in the
controls (Fig. 2b). RPGR is a PRA candidate gene (RetNet
database) since mutations in this gene have been de-
scribed to cause both XLRP in man [11] and X-linked
PRA in dogs [7].
Mutation screening
The presence of the RPGR deletion was verified in both
male PRA-affected dogs (by qPCR analysis of the deleted
exons 3–4 and the non-deleted exon 5) in comparison
to their parents (#3, #5), their maternal grandmother
(#1) and a healthy control. Compared to the control with
normal copy number for all three exons, the PRA-
affected dog (#10) lacked these exons, and his mother
(#5) showed just one copy for exons 3 and 4, while two
copies for exon 5 were identified in both of them. For all
three exons, two copies were evidenced in his grand-
mother (#1) and one copy in his father (#3; Fig. 2c).
QPCR-based screening of the deleted exon 4 in 13 fur-
ther individuals of the pedigree of the affected dogs re-
vealed no copy for another male sibling (#9) and one
copy for another female sibling (#8) as well as four fe-
male half-siblings (#13–14, #16–17). Two copies of exon
4 were shown for the maternal grandfather (#2), three
male half-siblings (#12, #15, #18) and the three breeding
partners of the mother (#4, #6–7). In total, qPCR
analyses verified the deletion in the three affected males
and the three mildly affected females in the investigated
Weimaraner pedigree (Fig. 2a). Additionally, the deletion
was demonstrated in three female dogs which so far
have not revealed any clinical symptoms. In 88 unrelated
control Weimaraners, the presence of exon 4 was
proven by normal copy numbers (data not shown). After
identification of RPGR deletion breakpoints, a break-
point PCR (diagnostic test) was performed for all 18 in-
dividuals of the pedigree confirming the results of RPGR
deletion screening as identified by qPCR and indicating
that the deletion comprises exons 1–4 of the RPGR gene
(data not shown).
In order to verify that the X-linked PRA in the investi-
gated Weimaraner pedigree is caused by a de novo muta-
tion, we investigated the biological parentage of both the
mother and the maternal grandparents of the PRA-
affected dogs by using the microsatellite marker based
parentage testing kits Canine Genotypes Panel 2.1 and
Canine Genotypes Panel 1.1. No inconsistencies con-
cerning the ancestry were identified in the investigated
individuals.
Mutation detection
In order to determine the genomic size of the RPGR de-
letion, the recombination breakpoints in IVS4 and 5′
UTR were analysed by PCR amplification employing
various primer sets. However, via UCSC database com-
parisons, a gap region was identified in the canine RPGR
sequence comprising 5′UTR, exon 1 with the start
codon and parts of intron 1. The sequence of this gap
was analysed by long-range PCR and subsequent primer
walking. The newly identified DNA sequence of this gap
region comprised 846 nt including a known long inter-
spersed nuclear element (LINE, repeat L1_Canis1_family
L1, UCSC genome browser) which occurs several times
in the canine genome (NCBI GenBank accession no
KU234669). A part of the newly identified genomic se-
quence of exon 1 was also detected in an mRNA isoform
of the RPGR gene in Canis lupus familiaris (accession
NM_001003126.1). As indicated by sequencing, the
breakpoint regions comprised three nucleotides (TTC,
Fig. 2d). The exact breakpoints are localized in the newly
identified 5′ sequence of RPGR gene (chrX: 33106747 +
190, UCSC genome browser, CanFam3.1, September
2011 assembly) and in IVS4 (chrX: 33102324), respect-
ively. Thus, the RPGR deletion comprised a maximum
size of 5,006 nt in the mutation-carrying Weimaraners.
Discussion
In the spring of 2015, ophthalmological examinations
had revealed retinopathy in two male symptomatic
Weimaraners from a single litter born in 2012. Female
dogs of this and another maternal litter were diagnosed
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with milder impairments. The veterinarians (at DOK)
named this form of retinal disease in Weimaraner retin-
opathy instead of PRA, because clear progression was
not documentable within the limited time span. None-
theless, since deleterious mutations in the RPGR gene
cause XLPRA, we use the original designation.
Here, whole exome sequencing was applied to map
the causative mutation for this early-onset form of PRA
in Weimaraners. Several litter mates had been diagnosed
with PRA, but the mode of inheritance was not clear
initially. One cause for RP in man are matrilineally
inherited mutations in the mitochondrial genome [17].
Analysis of the latter revealed no obvious pathogenic dif-
ferences in Weimaraners.
Using NGS-based whole exome analysis, a large dele-
tion comprising the first four exons including the start
codon was identified in the X-chromosomal RPGR gene
in PRA-affected Weimaraners. This gene encodes a
binding protein with a N-terminal domain homologous
to the regulator of chromosome condensation 1 (RCC1),
a guanine nucleotide exchange factor for the small
GTPase Ran [18], which is important for the association
with binding partners [19]. RPGR transcripts undergo
extensive alternative splicing e.g. in man, mouse and dog
[20, 21] producing constitutive and open reading frame
15 (ORF15) variants with an additional exon ORF15 by
using alternative polyadenylation and splice sites [22].
The constitutive variant is expressed in a wide variety of
tissues [20], whereas the ORF15 variant is predominantly
found in the retina [22]. The retinal subcellular
localization of RPGR protein is shown to be relatively
consistent across several mammalian species with high
enrichment in the photoreceptor connecting cilium [23].
Although the exact function of RPGR is not fully under-
stood, studies suggest that it plays an important role in
photoreceptor survival and its development [7]. RPGR
has been shown to interact with a variety of ciliary pro-
teins such as RPGRIP1 [24]. In this context six candidate
genes were discussed as potential modifiers in canine
XLPRA [25]. Mutations in the RPGR gene account for
over 70 % of X-linked RP [22, 26] and 15–20 % of all RP
[27]. Exon ORF15 is known to be a mutational hotspot
for XLRP, accounting for about 70 % of all disease-
causing mutations in the RPGR gene in humans [28].
Two canine animal models of ORF15 frame-shift muta-
tions have been published which resemble the human
phenotype in disease onset and progression [7, 21].
Thus, the Weimaraner breed is the third naturally oc-
curring pure-bred animal model for XLRP in addition to
Siberian husky and Samoyed [7, 21]. However, it is the
first one with a causative mutation localized in the
highly conserved 5′ terminus of the RPGR gene in con-
trast to the mutational hotspot in exon ORF15. Since
the identified RPGR deletion was not detectable in the
maternal grandparents of the affected male Weimaraners,
biological parentage had to be confirmed by microsatellite
marker testing. The deletion was also absent in 88
unrelated Weimaraner dogs, the deletion has occurred de
novo.
Based on comparisons with the location of CpG
islands in the human RPGR reference sequence (UCSC
genome browser, hg38, December 2013 assembly), we
suggest that the canine RPGR promotor region is situ-
ated in the newly identified DNA sequence in the 5′ se-
quence of the gene, outside of the 5′terminal breakpoint
region. Therefore, the deletion comprised the first four
exons including the start codon of the RPGR gene, sug-
gesting that the translation initiation is impaired result-
ing in the lack of RPGR gene products. Previous analyses
of mice lacking Rpgr showed that photoreceptor morph-
ology was initially normal but photoreceptor cell degen-
eration was noted over time, suggesting that the Rpgr
gene is required for long-term maintenance of photore-
ceptors [29]. This correlates with the PRA form studied
here in Weimaraners which presented with initial PRA
symptoms at ~2.5 years of age. In addition, it has been
shown that a 2 nt- frameshift microdeletion causes
photoreceptor degeneration in canine X-linked PRA
[30]. Finally, UCSC Genome Browser comparisons with
human RPGR transcripts demonstrate that a functional
transcript lacking the first four exons has not been ob-
served so far.
Our molecular genetic results of the RPGR deletion as
evidenced in the Weimaraner pedigree studied (Fig. 2a)
were entirely consistent with the respective results of
ophthalmological investigations by DOK veterinarians.
The deletion was identified in hemizygous state in three
male Weimaraner litter mates all of which were ophthal-
mologically diagnosed with PRA and showed diffuse
tapetal hyperreflectivity, attenuated vessels (Fig. 1b) and
visual disturbances in twilight compared to a dog with
normal central fundus (Fig 1a) and without visual im-
pairments. In six female individuals of the pedigree the
deletion was found in heterozygous state, and ophthal-
mological investigations in three of them revealed mild
symptoms of peripheral hyperreflexia (data not shown).
These findings are in accordance with a recessive mode
of X-linked inheritance in which hemizygous males are
usually severely affected, while female individuals carrying
the deletion in heterozygous state may be asymptomatic
or, in case of non-random or skewed X-inactivation, may
present a mild phenotype [31].
Conclusions
The findings of the present study demonstrate the value of
an existing DNA biobank combined with modern tools
available for genomic mutation analyses to aid rapid iden-
tification of the genetic cause of a spontaneously occurring
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disease in a dog breed. Without the DNA biobank for
Weimaraner dogs, it would have been impossible to in-
clude the deceased maternal grandparents in this study.
This implies that the RPGR deletion screening would have
had to be performed in a much larger population of
Weimaraners. In short, a diagnostic test has been estab-
lished, that allows for mutation screening for both very
young and (still) healthy dogs. Thus, precise conclusions
may be drawn, and the PRA mutation may be eradicated
from the respective Weimaraner line.
Additional file
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